Mark Gustavson

Mark Gustavson

Company: AstraZeneca

Job title: Senior Director, Oncology Translational Medicine

Seminars:

Computational Pathology – the Next Revolution in Companion Diagnostics 2:30 pm

IHC is commonly used to measure target levels of ADCs despite the fact that it is semi-quantitative Sharing a method developed using image analysis and computational methods to score membrane targets with a continuous quantitative manner This method enables target expression per cell to be measured and allows for the modelling of bystander effectsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.